Wake-Up Call: Why Pharma Must Take the Lead on Connected Devices

This session explores the untapped potential of connected devices in healthcare and the urgent need for industry leaders to reclaim their stake in this $50 billion market (Statista). While tech giants like Apple, Huawei, and Samsung are successfully launching wellness devices and apps, healthcare companies are lagging behind, missing opportunities to lead innovation in patient monitoring, chronic disease management, and preventative care. According to Deloitte, the global connected care market is projected to reach US$190 billion by 2032, with 37% of consumers already regularly using digital monitoring devices to track health conditions. Deloitte highlights that connected devices could reduce healthcare costs by up to 20% through improved patient adherence and early intervention.

Attendees to this session will gain insights into why pharmaceutical and healthcare companies ceded ground to Silicon Valley, the risks of continued inaction, and actionable strategies to develop platforms that integrate connected devices into patient-centric care models. Join this thought-provoking discussion to learn how pharma, insurers, and hospital systems can leverage the connected care sector to drive better outcomes, improve patient engagement, and secure their place in the future of health technology.